Characterization of Exochelins of theMycobacterium bovis Type Strain and BCG Substrains

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Infection and Immunity

• Publication date

  1999-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/IAI.67.4.2035-2039.1999PMID 10085056PMCID PMC96566
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mycobacterial speciation.

  1998cited by this paper
• Transmission between HIV‐infected patients of multidrug‐resistant tuberculosis caused by Mycobacterium bovis

  1997cited by this paper
• Protein sequence and structural studies employing matrix-assisted laser desorption ionization-high energy collision-induced dissociation

  1997cited by this paper
• Exochelins of Mycobacterium tuberculosis remove iron from human iron- binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall

  1996cited by this paper
• Idiopathic disseminated bacillus Calmette-Guérin infection: a French national retrospective study.

  1996cited by this paper
• Characterization of exochelins of Mycobacterium avium: evidence for saturated and unsaturated and for acid and ester forms

  1996cited by this paper
• Delayed extraction matrix‐assisted laser desorption time‐of‐flight mass spectrometry

  1995cited by this paper
• Isolation, purification and structure of exochelin MS, the extracellular siderophore from Mycobacterium smegmatis.

  1995cited by this paper
• Iron acquisition by Mycobacterium tuberculosis: isolation and characterization of a family of iron-binding exochelins.

  1995influential reference
• Determination of the structure of exochelin MN, the extracellular siderophore from Mycobacterium neoaurum.

  1995cited by this paper
• Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature.

  1994cited by this paper
• Zoonotic tuberculosis (Mycobacterium bovis): memorandum from a WHO meeting (with the participation of FAO).

  1994cited by this paper
• Use of various genetic markers in differentiation of Mycobacterium bovis strains from animals and humans and for studying epidemiology of bovine tuberculosis

  1994cited by this paper
• A NOSOCOMIAL OUTBREAK OF MULTIDRUG‐RESISTANT MYCOBACTERIUM BOVIS AMONG HIV‐INFECTED PATIENTS

  1994cited by this paper
• Efficacy of BCG Vaccine in the Prevention of Tuberculosis: Meta-analysis of the Published Literature

  1994cited by this paper
• Mycobacterium bovis Infections in San Diego: A Clinicoepidemiologic Study of 73 Patients and a Historical Review of a Forgotten Pathogen

  1993cited by this paper
• A nosocomial outbreak of multidrug‐resistant Mycobacterium bovis among HIV‐infected patients.: A case‐control study

  1993cited by this paper
• Mycobactins and exochelins of Mycobacterium tuberculosis, M. bovis, M. africanum and other related species.

  1988cited by this paper
• BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics.

  1984cited by this paper
• The Mycobacteria : a sourcebook

  1984cited by this paper
• A new group of water-soluble iron-binding compounds from Mycobacteria: the exochelins.

  1975cited by this paper
• Extracellular iron acquisition by mycobacteria: role of the exochelins and evidence against the participation of mycobactin

  1975cited by this paper

• The diversity and utility of arylthiazoline and aryloxazoline siderophores: Challenges of coordination chemistry, biological activity and selected applications

  2024cites this paper
• The Iron Response of Mycobacterium tuberculosis and Its Implications for Tuberculosis Pathogenesis and Novel Therapeutics

  2022cites this paper
• The diversity and utility of arylthiazoline and aryloxazoline siderophores: challenges of total synthesis

  2022cites this paper
• Understanding the Potential and Risk of Bacterial Siderophores in Cancer

  2022cites this paper
• Comparing the Metabolic Capabilities of Bacteria in the Mycobacterium tuberculosis Complex

  2019cites this paper
• Chemistry and Biology of Salicyl-Capped Siderophores

  2018cites this paper
• An Engineered Synthetic Pathway for Discovering Nonnatural Nonribosomal Peptides in Escherichia coli

  2017cites this paper
• Iron Homeostasis in Mycobacterium tuberculosis: Mechanistic Insights into Siderophore-Mediated Iron Uptake

  2016cites this paper
• Lipidomic Analysis Links Mycobactin Synthase K to Iron Uptake and Virulence in M. tuberculosis

  2015cites this paper
• The Exochelins of Pathogenic Mycobacteria: Unique, Highly Potent, Lipid- and Water-Soluble Hexadentate Iron Chelators with Multiple Potential Therapeutic Uses

  2014cites this paper
• A comparative lipidomics platform for chemotaxonomic analysis of Mycobacterium tuberculosis.

  2011cites this paper
• The TB Structural Genomics Consortium: a decade of progress.

  2011cites this paper
• Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophages.

  2010cites this paper
• Mycolic Acid/Cyclopropane Fatty Acid/Fatty Acid Biosynthesis and Health Relations

  2010cites this paper
• The Use of Spectroscopic Techniques in the Characterization of Mycobacterial Metabolites

  2009cites this paper
• 10 Iron Uptake in Mycobacteria

  2008cites this paper
• Hereditary hemochromatosis results in decreased iron acquisition and growth by Mycobacterium tuberculosis within human macrophages

  2007cites this paper
• Recombinant BCG vaccine candidates.

  2007cites this paper
• Strain-Dependent Variation in Mycobacterium bovis BCG-Induced Human T-Cell Activation and Gamma Interferon Production In Vitro

  2007cites this paper
• Iron chelation as therapy for HIV and Mycobacterium tuberculosis co-infection under conditions of iron overload.

  2006cites this paper
• A second-generation anti TB vaccine is long overdue

  2004cites this paper
• Iron, mycobacteria and tuberculosis.

  2004cites this paper
• Participation of fad and mbt Genes in Synthesis of Mycobactin in Mycobacterium smegmatis

  2004cites this paper
• A mycobacterial iron chelator, desferri-exochelin, induces hypoxia-inducible factors 1 and 2, NIP3, and vascular endothelial growth factor in cancer cell lines.

  2002cites this paper
• Inhibition of the in-vitro growth of Mycobacterium tuberculosis by a phytosiderophore.

  2001cites this paper
• Iron as a candidate in virulence and pathogenesis in mycobacteria and other microorganisms

  2000influential citation
• The salicylate-derived mycobactin siderophores of Mycobacterium tuberculosis are essential for growth in macrophages.

  2000cites this paper
• Iron metabolism in pathogenic bacteria.

  2000cites this paper
• Annals of Clinical Microbiology and Antimicrobials Open Access a Second-generation Anti Tb Vaccine Is Long Overdue

  year unknowncites this paper